Skip to main content
Erschienen in: Monatsschrift Kinderheilkunde 2/2016

01.02.2016 | Aphthen | CME

Autoinflammatorische Syndrome im Kindesalter

verfasst von: Prof. Dr. G. Horneff

Erschienen in: Monatsschrift Kinderheilkunde | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Systemische autoinflammatorische Erkrankungen sind eine Gruppe von erblichen und nichterblichen Erkrankungen des angeborenen Immunsystems, gekennzeichnet durch in unregelmäßigen Zeitabständen wiederkehrende, scheinbar grundlose Entzündungen mit Manifestationen an der Haut, den Schleimhäuten, Gelenken, Knochen, im Magen-Darm-Trakt, aber auch an Gefäßen und ZNS. Amyloidose und andere mögliche schwere langfristige Komplikationen sind von Bedeutung. Fortschritte in der Genetik und Molekularbiologie haben das Verständnis der Pathogenese dieser Erkrankungen, einschließlich familiärem Mittelmeerfieber, Mevalonatkinase-Mangel-Syndrom, Tumornekrosefaktorrezeptor-assoziiertem periodischem Syndrom, Cryopyrin-assoziierten periodischen Syndromen und anderen verbessert. Die überwiegende Mehrheit dieser Erkrankungen basiert auf einer Aktivierung des Interleukin (IL)-1-Wegs, wodurch die IL-1-Inhibition sich als eine therapeutische Option anbietet. Andere Syndrome werden durch eine granulomatöse Entzündung gekennzeichnet. Neuere autoinflammatorische Erkrankungen, „chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature“ (CANDLE) und „STING-associated vasculopathy with onset in infancy“ (SAVI) dagegen sind z. B. Interferon getrieben.
Literatur
1.
Zurück zum Zitat Yalçinkaya F, Ozen S, Ozçakar ZB et al (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 48:395–398 Yalçinkaya F, Ozen S, Ozçakar ZB et al (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 48:395–398
2.
Zurück zum Zitat Booty MG, Chae JJ, Masters SL et al (2009) Familial Mediterranean fever with a single MEFV mutation: Where is the second hit? Arthritis Rheum 60:1851–1861PubMedCentralCrossRefPubMed Booty MG, Chae JJ, Masters SL et al (2009) Familial Mediterranean fever with a single MEFV mutation: Where is the second hit? Arthritis Rheum 60:1851–1861PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Kallinich T, Wittkowski H, Keitzer R et al (2010) Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever. Ann Rheum Dis 69:677–682CrossRefPubMed Kallinich T, Wittkowski H, Keitzer R et al (2010) Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever. Ann Rheum Dis 69:677–682CrossRefPubMed
4.
Zurück zum Zitat Meinzer U, Quartier P, Alexandra JF et al (2011) Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 41:265–271CrossRefPubMed Meinzer U, Quartier P, Alexandra JF et al (2011) Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 41:265–271CrossRefPubMed
5.
Zurück zum Zitat Houten SM, Kuis W, Duran M et al (1999) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 22:175–177CrossRefPubMed Houten SM, Kuis W, Duran M et al (1999) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 22:175–177CrossRefPubMed
6.
Zurück zum Zitat Prietsch V, Mayatepek E, Krastel H et al (2003) Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics 111:258–261CrossRefPubMed Prietsch V, Mayatepek E, Krastel H et al (2003) Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics 111:258–261CrossRefPubMed
7.
Zurück zum Zitat Hilst JC van der, Bodar EJ, Barron KS et al (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301–310 Hilst JC van der, Bodar EJ, Barron KS et al (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301–310
8.
Zurück zum Zitat Gattorno M, Martini A (2010) Treatment of autoinflammatory syndromes. Curr Opin Pediatr 22:771–778CrossRefPubMed Gattorno M, Martini A (2010) Treatment of autoinflammatory syndromes. Curr Opin Pediatr 22:771–778CrossRefPubMed
9.
Zurück zum Zitat Hull KM, Drewe E, Aksentijevich I et al (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368 Hull KM, Drewe E, Aksentijevich I et al (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368
10.
Zurück zum Zitat Aksentijevich I, Galon J, Soares M et al (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301–314PubMedCentralCrossRefPubMed Aksentijevich I, Galon J, Soares M et al (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301–314PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Pelagatti MA, Meini A, Caorsi R et al (2011) Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum 63:1141–1150PubMedCentralCrossRefPubMed Pelagatti MA, Meini A, Caorsi R et al (2011) Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum 63:1141–1150PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Gattorno M, Pelagatti MA, Meini A et al (2008) Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 58:1516–1520CrossRefPubMed Gattorno M, Pelagatti MA, Meini A et al (2008) Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 58:1516–1520CrossRefPubMed
13.
Zurück zum Zitat Muckle TJ, Wells M (1962) Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 31:235–248PubMed Muckle TJ, Wells M (1962) Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 31:235–248PubMed
14.
Zurück zum Zitat Goldbach-Mansky R, Dailey NJ, Canna SW et al (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 355:581–589PubMedCentralCrossRefPubMed Goldbach-Mansky R, Dailey NJ, Canna SW et al (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 355:581–589PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Tanaka N, Izawa K, Saito MK et al (2011) High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study. Arthritis Rheum 63:3625–3632PubMedCentralCrossRefPubMed Tanaka N, Izawa K, Saito MK et al (2011) High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study. Arthritis Rheum 63:3625–3632PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607–612CrossRefPubMed Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607–612CrossRefPubMed
17.
Zurück zum Zitat Aksentijevich I, Masters SL, Ferguson PJ et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360:2426–2437PubMedCentralCrossRefPubMed Aksentijevich I, Masters SL, Ferguson PJ et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360:2426–2437PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Marrakchi S, Guigue P, Renshaw BR et al (2011) Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 365:620–628CrossRefPubMed Marrakchi S, Guigue P, Renshaw BR et al (2011) Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 365:620–628CrossRefPubMed
19.
Zurück zum Zitat Agarwal AK, Xing C, DeMartino GN et al (2010) PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 87:866–872PubMedCentralCrossRefPubMed Agarwal AK, Xing C, DeMartino GN et al (2010) PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 87:866–872PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Kluk J, Rustin M, Brogan PA et al (2014) Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a report of a novel mutation and review of the literature. Br J Dermatol 170:215–217PubMedCentralCrossRefPubMed Kluk J, Rustin M, Brogan PA et al (2014) Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a report of a novel mutation and review of the literature. Br J Dermatol 170:215–217PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Liu Y, Ramot Y, Torrelo A et al (2012) Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 64:895–907PubMedCentralCrossRefPubMed Liu Y, Ramot Y, Torrelo A et al (2012) Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 64:895–907PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Wise CA, Gillum JD, Seidman CE et al (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961–969CrossRefPubMed Wise CA, Gillum JD, Seidman CE et al (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961–969CrossRefPubMed
24.
Zurück zum Zitat Rose CD, Martin TM, Wouters CH (2011) Blau syndrome revisited. Curr Opin Rheumatol 23:411–418CrossRefPubMed Rose CD, Martin TM, Wouters CH (2011) Blau syndrome revisited. Curr Opin Rheumatol 23:411–418CrossRefPubMed
25.
Zurück zum Zitat Simonini G, Xu Z, Caputo R et al (2012) Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum 65:513–518CrossRef Simonini G, Xu Z, Caputo R et al (2012) Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum 65:513–518CrossRef
26.
Zurück zum Zitat Cliffe ST, Kramer JM, Hussain K et al (2009) SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. Hum Mol Genet 18:2257–2265CrossRefPubMed Cliffe ST, Kramer JM, Hussain K et al (2009) SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. Hum Mol Genet 18:2257–2265CrossRefPubMed
27.
Zurück zum Zitat Feder HM, Salazar JC (2010) A clinical review of 105 patients with PFAPA. Acta Paediatr 99:178–184PubMed Feder HM, Salazar JC (2010) A clinical review of 105 patients with PFAPA. Acta Paediatr 99:178–184PubMed
28.
Zurück zum Zitat Cochard M, Clet J, Le L et al (2010) PFAPA syndrome is not a sporadic disease. Rheumatology (Oxford) 49:1984–1987 Cochard M, Clet J, Le L et al (2010) PFAPA syndrome is not a sporadic disease. Rheumatology (Oxford) 49:1984–1987
29.
Zurück zum Zitat Renko M, Salo E, Putto-Laurila A et al (2007) A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr 151:289–292CrossRefPubMed Renko M, Salo E, Putto-Laurila A et al (2007) A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr 151:289–292CrossRefPubMed
30.
Zurück zum Zitat Tasher D, Stein M, Dalal I et al (2008) Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes. Acta Paediatr 97:1090–1092CrossRefPubMed Tasher D, Stein M, Dalal I et al (2008) Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes. Acta Paediatr 97:1090–1092CrossRefPubMed
31.
Zurück zum Zitat Ferguson PJ, Chen S, Tayeh MK et al (2005) Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42:551–557PubMedCentralCrossRefPubMed Ferguson PJ, Chen S, Tayeh MK et al (2005) Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42:551–557PubMedCentralCrossRefPubMed
Metadaten
Titel
Autoinflammatorische Syndrome im Kindesalter
verfasst von
Prof. Dr. G. Horneff
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Monatsschrift Kinderheilkunde / Ausgabe 2/2016
Print ISSN: 0026-9298
Elektronische ISSN: 1433-0474
DOI
https://doi.org/10.1007/s00112-015-0036-0

Weitere Artikel der Ausgabe 2/2016

Monatsschrift Kinderheilkunde 2/2016 Zur Ausgabe

Mitteilungen der ÖGKJ

Mitteilungsseiten der ÖGKJ

Pädiatrie aktuell

Für Sie gelesen

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.